Compare NFGC & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NFGC | ABCL |
|---|---|---|
| Founded | 2016 | 2012 |
| Country | Canada | Canada |
| Employees | N/A | N/A |
| Industry | Precious Metals | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 928.8M | 1.1B |
| IPO Year | 2021 | 2020 |
| Metric | NFGC | ABCL |
|---|---|---|
| Price | $2.18 | $5.11 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $8.40 |
| AVG Volume (30 Days) | 1.7M | ★ 6.2M |
| Earning Date | 05-11-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 10.91 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $75,128,000.00 |
| Revenue This Year | $3,542.00 | N/A |
| Revenue Next Year | $118.57 | $21.85 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 160.56 |
| 52 Week Low | $1.19 | $1.94 |
| 52 Week High | $3.59 | $6.52 |
| Indicator | NFGC | ABCL |
|---|---|---|
| Relative Strength Index (RSI) | 54.37 | 75.89 |
| Support Level | $1.85 | $3.89 |
| Resistance Level | $2.34 | $6.52 |
| Average True Range (ATR) | 0.12 | 0.35 |
| MACD | 0.02 | 0.09 |
| Stochastic Oscillator | 67.78 | 93.92 |
New Found Gold Corp is a mineral exploration company engaged in the acquisition, exploration and evaluation of resource properties with a focus on gold properties located in the Provinces of Newfoundland and Labrador and Ontario, Canada. The Company's exploration is focused on discovering and delineating gold resources. The Company has one material property: the Queensway Project located in Newfoundland, Canada (the Queensway Project).
AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.